Patents by Inventor Yaacob Yanay

Yaacob Yanay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230338432
    Abstract: Disclosed herein are methods and compositions comprising placental adherent stromal cells for treating viral infections and sequelae thereof.
    Type: Application
    Filed: March 11, 2021
    Publication date: October 26, 2023
    Applicant: PLURISTEM LTD.
    Inventors: Yaacob YANAY, Rachel OFIR, Marc TRITEL
  • Publication number: 20220202875
    Abstract: Disclosed herein are methods and compositions comprising placental adherent stromal cells, conditioned media derived from a cultured placental ASC, lysates thereof, and fractions thereof, for treating a skin condition (e.g. a compromised skin barrier, acne, wrinkles, hyper/hypo-pigmentation, dryness, elastosis); increasing skin volume, and preventing or treating alopecia and related conditions.
    Type: Application
    Filed: March 14, 2022
    Publication date: June 30, 2022
    Applicant: PLURISTEM LTD.
    Inventors: Yaacob YANAY, Lior RAVIV, Murielle AGASSI, Sagi MORAN
  • Publication number: 20220046883
    Abstract: Disclosed herein are methods of producing one or more cannabinoid compounds, expanding cells that produce the compounds, cannabinoid compounds produced by the methods, pharmaceutical compositions comprising the cannabinoid compounds, and methods of producing and utilizing the compounds and compositions.
    Type: Application
    Filed: April 20, 2020
    Publication date: February 17, 2022
    Applicant: PLURISTEM LTD.
    Inventors: Yaacob YANAY, Lior RAVIV
  • Publication number: 20210353687
    Abstract: Disclosed herein are methods and compositions comprising adherent stromal cells.
    Type: Application
    Filed: June 18, 2019
    Publication date: November 18, 2021
    Applicant: PLURISTEM LTD.
    Inventors: Arie EISENKRAFT, Yaacob YANAY, Rachel OFIR
  • Publication number: 20210338740
    Abstract: Disclosed herein are pharmaceutical compositions and methods comprising or utilizing placental adherent stromal cells. The pharmaceutical compositions may be indicated for ameliorating or treating various disorders, e.g., impaired glucose tolerance. Alternatively, the pharmaceutical composition may be indicated for ameliorating or treating systemic inflammation, e.g., in a subject with impaired glucose tolerance. The pharmaceutical compositions may further include pharmacologically acceptable excipients.
    Type: Application
    Filed: November 6, 2019
    Publication date: November 4, 2021
    Applicant: PLURISTEM LTD.
    Inventors: Zami ABERMAN, Yaacob YANAY, Rachel OFIR, Marc TRITEL, Hoshea Yissachar ALLEN, Niva SHRAGA HELED
  • Publication number: 20210283189
    Abstract: Disclosed herein are methods and compositions comprising placental adherent stromal cells for treating viral infections and sequelae thereof.
    Type: Application
    Filed: March 11, 2021
    Publication date: September 16, 2021
    Applicant: PLURISTEM LTD.
    Inventors: Yaacob Yanay, Rachel Ofir, Marc Tritel
  • Publication number: 20210228635
    Abstract: Disclosed herein are pharmaceutical compositions and therapeutic dosage regimens comprising or utilizing adherent stromal cells. The adherent stromal cells may be derived e.g. from placental tissue, from adipose tissue, or from bone marrow. The pharmaceutical compositions may be indicated for treating various disorders, e.g. ischemic disorders, hematopoietic disorders, and neurodegenerative disorders, inflammatory disorders, and neoplasms. The pharmaceutical compositions may further include pharmacologically acceptable excipients.
    Type: Application
    Filed: June 10, 2019
    Publication date: July 29, 2021
    Applicant: PLURISTEM LTD.
    Inventors: Zami ABERMAN, Yaacob YANAY, Rachel OFIR, Marc TRITEL
  • Publication number: 20200368290
    Abstract: Disclosed herein are methods and compositions comprising placental adherent stromal cells, conditioned media derived from a cultured placental ASC, lysates thereof, and fractions thereof, for treating a skin condition (e.g. a compromised skin barrier, acne, wrinkles, hyper/hypo-pigmentation, dryness, elastosis); increasing skin volume, and preventing or treating alopecia and related conditions.
    Type: Application
    Filed: August 11, 2020
    Publication date: November 26, 2020
    Inventors: Yaacob Yanay, Lior Raviv, Murielle Agassi, Sagi Moran